Olivia Ware

Olivia brings more than 20 years of experience in biotech and pharmaceutical drug development, commercialization, and healthcare management. Most recently, Olivia served as Senior Vice President, BTK Franchise at Principia Biopharma which was acquired by Sanofi in 2020. Prior to that, she was the Senior Vice President for commercial activities at Proteus Digital Health, Inc., a marketing and strategy consultant, and Chief Commercial Officer at CytRx Corporation. Olivia served in a variety of roles of increasing responsibility at Genentech in sales and marketing, managed care and leading global cross-functional teams. Olivia currently serves on the public boards of Revance Therapeutics, Inc., and Ambrx, Inc. Olivia holds an M.B.A. in Finance and Marketing from the University of North Carolina, Chapel Hill, and an A.B. from Davidson College.